Stimuli-Responsive Nanomedicine for Hematologic Malignancies: Rational Design, Functional Integration, Applications, and Challenges
Journal of Materials Chemistry B · 2026
DOI: 10.1039/d6tb02409b ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Shuangshuang Jia und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Hematologic malignancies present unique challenges for drug delivery due to their systemic dissemination, heterogeneous disease niches, protective tumor microenvironments, and therapy-resistant residual disease. Stimuli-responsive nanomedicines provide a promising strategy to...
Zitieren
APA
Jia, S., Li, H., Chu, B., & Qu, Y. (2026). Stimuli-Responsive Nanomedicine for Hematologic Malignancies: Rational Design, Functional Integration, Applications, and Challenges. Journal of Materials Chemistry B. https://doi.org/10.1039/d6tb02409b
Vancouver
Jia S, Li H, Chu B, Qu Y. Stimuli-Responsive Nanomedicine for Hematologic Malignancies: Rational Design, Functional Integration, Applications, and Challenges. Journal of Materials Chemistry B. 2026. doi:10.1039/d6tb02409b
BibTeX
@article{Jia2026,
author = {Jia, Shuangshuang and Li, He and Chu, Bingyang and Qu, Ying},
title = {Stimuli-Responsive Nanomedicine for Hematologic Malignancies: Rational Design, Functional Integration, Applications, and Challenges},
journal = {Journal of Materials Chemistry B},
year = {2026},
doi = {10.1039/d6tb02409b}
}
EUVIMED